MAPK/ERK-CBP-RFPL-3 Mediates Adipose-Derived Stem Cell-Induced Tumor Growth in Breast Cancer Cells by Activating Telomerase Reverse Transcriptase Expression

Adipose-derived stem cells (ASCs) improve the self-renewal and survival of fat grafts in breast reconstruction after oncology surgery. However, ASCs have also been found to enhance breast cancer growth, and its role in tumor proliferation remains largely elusive. Here, we explored a novel mechanism that mediates hTERT reactivation during ASC-induced tumor growth in breast cancer cells. In this study, we found the proliferative ability of breast cancer cells markedly increased with ASC coculture. To explore the molecular mechanism, we treated cells with anibody/inhibitor and found that the activation of MEK-ERK pathway was triggered in breast cancer cells by SCF secreted from ASCs, leading to the nuclear recruitment of CBP. As a coactivator of hTERT, CBP subsequently coordinated with RFPL-3 upregulated hTERT transcription and telomerase activity. The inhibition of CBP and RFPL-3 abrogated the activation of hTERT transcription and the promotion of proliferation in breast cancer cells with cocultured ASCs in vitro and in vivo. Collectively, our study findings indicated that CBP coordination with RFPL-3 promotes ASC-induced breast cancer cell proliferation by anchoring to the hTERT promoter and upregulating telomerase activity, which is activated by the MAPK/ERK pathway.

[1]  H. Kreipe,et al.  Transcription factor AP‐2beta in development, differentiation and tumorigenesis , 2021, International journal of cancer.

[2]  C. Bai,et al.  A new monoclonal antibody that blocks dimerisation and inhibits c-kit mutation-driven tumour growth , 2021, Journal of Cancer Research and Clinical Oncology.

[3]  N. Zarghami,et al.  Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways. , 2020, Biochimie.

[4]  J. Nandakumar,et al.  Molecular mechanisms of telomere biology disorders. , 2020, The Journal of biological chemistry.

[5]  L. Sapio,et al.  Targeting CREB in Cancer Therapy: A Key Candidate or One of Many? An Update , 2020, Cancers.

[6]  Yu Jin,et al.  Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways , 2020, Gastric Cancer.

[7]  Yu Qin,et al.  Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation , 2020, Cell Death & Disease.

[8]  Young-sil Yoon,et al.  Transcriptional co-activator regulates melanocyte differentiation and oncogenesis by integrating cAMP and MAPK/ERK pathways , 2020, bioRxiv.

[9]  V. Tergaonkar,et al.  Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential , 2020, Cancers.

[10]  G. Peters,et al.  Targeting telomerase for its advent in cancer therapeutics. , 2020, Medicinal research reviews.

[11]  S. Park,et al.  Development and characterization of a fully human antibody targeting SCF/c-kit signaling. , 2020, International journal of biological macromolecules.

[12]  Ying Xu,et al.  ERK/MAPK signalling pathway and tumorigenesis , 2020, Experimental and therapeutic medicine.

[13]  Simone Brogi,et al.  Telomerase-based cancer therapeutics: a review on their clinical trials. , 2020, Current topics in medicinal chemistry.

[14]  Ping Chen,et al.  Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1) , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[15]  Y. Cong,et al.  Role of telomerase in the tumour microenvironment , 2019, Clinical and experimental pharmacology & physiology.

[16]  Kangdong Liu,et al.  Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro , 2019, Cancer Cell International.

[17]  S. Luo,et al.  Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b. , 2019, Cellular signalling.

[18]  C. Govind,et al.  Mesenchymal stem cells: Cell therapy and regeneration potential , 2019, Journal of tissue engineering and regenerative medicine.

[19]  P. Gentile,et al.  Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities , 2019, International journal of molecular sciences.

[20]  W. Jones,et al.  CBP/p300 drives the differentiation of Regulatory T cells through transcriptional and non-transcriptional mechanisms. , 2019, Cancer research.

[21]  A. Amadori,et al.  A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer , 2019, Cell Death & Disease.

[22]  A. Slusher,et al.  Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer , 2019, Cancers.

[23]  Ting Zhang,et al.  The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling , 2019, Cell Death & Disease.

[24]  F. Jacobsen,et al.  Influence of preadipocyte-conditioned medium on the proliferation and invasive potential of breast cancer cell lines in vitro , 2018, Archives of Gynecology and Obstetrics.

[25]  Mohamed A. Nasr,et al.  Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells , 2018, Biology Open.

[26]  A. Perin,et al.  The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients , 2018, British Journal of Cancer.

[27]  C. Qian,et al.  c-Kit-Positive Adipose Tissue-Derived Mesenchymal Stem Cells Promote the Growth and Angiogenesis of Breast Cancer , 2017, BioMed research international.

[28]  Wenlin Huang,et al.  RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth , 2015, Oncotarget.

[29]  G. Wei,et al.  Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells , 2014, Oncotarget.

[30]  S. Agarwal,et al.  The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling. , 2013, Cellular signalling.

[31]  K. Krause,et al.  Primate-specific RFPL1 gene controls cell-cycle progression through cyclin B1/Cdc2 degradation , 2011, Cell Death and Differentiation.

[32]  P. Khaitovich,et al.  Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. , 2008, American journal of human genetics.

[33]  A. Shukla,et al.  Measuring agonist-induced ERK MAP kinase phosphorylation for G-protein-coupled receptors. , 2019, Methods in cell biology.